Oppenheimer analyst Suraj Kalia downgraded Procept BioRobotics Corp (NASDAQ: PRCT) from Outperform to Perform.The analyst comments "PROCEPT reported 4Q25 revenues ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE